In the recent past, there have been significant regulatory developments around ‘e-cigarettes’ and similar devices, colloquially referred to as ‘vapes’. Below is a brief description of certain key developments from jurisdictions across the world, with consequent opportunities in the Indian context.
A. USA: FDA’s Orders Against JUUL
The US Food and Drug Administration (FDA) announced, on June 23, 2022, that it is banning the sale of ‘JUUL’ e-cigarettes, one of the most well-known brands of vapes, in the USA.
The above decision of the FDA was based on its determination that there was insufficient evidence to demonstrate that marketing of JUUL’s products would be appropriate for the protection of public health . Having said that, the FDA clarified that it had not received clinical information to suggest an immediate hazard associated with the use of JUUL’s products.
Please click here to read the full article by Upendra Nath Sharma and Akshath Mithal, published in ET Insights.
Akshath is experienced in corporate advisory, due diligence, and transaction support for both strategic private equity investments and financial investments by foreign investors in Indian entities.